Insulet Corporation revised earnings guidance for the year ending December 31, 2024. For the year ending December 31, 2024, the company is raising its expected revenue growth to a range of 14% to 18% (previously 12% to 17%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180.1 USD | +5.43% | -3.84% | -17.01% |
14/05 | Insulet Shares Rise Despite Blue Orca's Short Position | MT |
10/05 | Raymond James Adjusts Price Target on Insulet to $213 From $218 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.01% | 11.96B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.57B | |
+2.64% | 49.95B | |
+6.58% | 43.84B | |
+4.91% | 41.71B | |
+21.98% | 31.59B | |
+14.45% | 25.3B | |
-5.81% | 23.94B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Insulet Corporation Revises Earnings Guidance for the Year Ending December 31, 2024